The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
Recruiting
Phase 4
Interventional Study
Velocardiofacial Syndrome
Williams Syndrome
Fragile X Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 400 (estimated)
- Sponsor
- The Chaim Sheba Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* chromosomal deletion proven by FISH examination
Exclusion Criteria:
Contacts